Väster{dot over (a)}s, Sweden

Claudio Pecorari

This inventor holds 2 USPTO granted patents. Top assignee: Abb Ab. Active years: 2005.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 153(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Claudio Pecorari

Introduction

Claudio Pecorari is a notable inventor based in Västerås, Sweden. He has made significant contributions to the fields of pharmaceuticals, chemicals, and food processing through his innovative methods and devices. With a total of 2 patents, Pecorari's work focuses on enhancing the monitoring and control of various processes.

Latest Patents

Pecorari's latest patents include a method and device for monitoring and controlling a process. This invention allows for the monitoring of biological activity and bio-mass of micro-organisms in pharmaceutical, chemical, or food processes. The state of the process is detected by monitoring viscosity, aggregate size, and the content of a dispersion of proteins, crystalline particles, or fat droplets. The monitoring is achieved through acoustic spectroscopy, which provides valuable insights into the micro-organisms and bio-molecules produced during the process.

Career Highlights

Claudio Pecorari is currently associated with Abb Ab, where he continues to develop innovative solutions in his field. His expertise in process monitoring has positioned him as a key player in advancing technology within the industry.

Collaborations

Pecorari has collaborated with talented individuals such as Stefan Backa and Anna Kornfeldt. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Claudio Pecorari's contributions to innovation in process monitoring and control demonstrate his commitment to advancing technology in pharmaceuticals, chemicals, and food processing. His work continues to impact these industries positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…